TMPRSS2 promotes SARS-CoV-2 evasion from NCOA7-mediated restriction.
COVID-19
/ virology
Cell Line
Endosomes
/ metabolism
Furin
/ genetics
Gene Expression
Humans
Immune Evasion
Interferons
/ metabolism
Lysosomes
/ enzymology
Nuclear Receptor Coactivators
/ genetics
Protein Isoforms
Proteolysis
SARS-CoV-2
/ physiology
Serine Endopeptidases
/ genetics
Spike Glycoprotein, Coronavirus
/ metabolism
Viral Pseudotyping
Virus Internalization
Journal
PLoS pathogens
ISSN: 1553-7374
Titre abrégé: PLoS Pathog
Pays: United States
ID NLM: 101238921
Informations de publication
Date de publication:
11 2021
11 2021
Historique:
received:
16
07
2021
accepted:
09
11
2021
revised:
06
12
2021
pubmed:
23
11
2021
medline:
24
12
2021
entrez:
22
11
2021
Statut:
epublish
Résumé
Interferons play a critical role in regulating host immune responses to SARS-CoV-2, but the interferon (IFN)-stimulated gene (ISG) effectors that inhibit SARS-CoV-2 are not well characterized. The IFN-inducible short isoform of human nuclear receptor coactivator 7 (NCOA7) inhibits endocytic virus entry, interacts with the vacuolar ATPase, and promotes endo-lysosomal vesicle acidification and lysosomal protease activity. Here, we used ectopic expression and gene knockout to demonstrate that NCOA7 inhibits infection by SARS-CoV-2 as well as by lentivirus particles pseudotyped with SARS-CoV-2 Spike in lung epithelial cells. Infection with the highly pathogenic, SARS-CoV-1 and MERS-CoV, or seasonal, HCoV-229E and HCoV-NL63, coronavirus Spike-pseudotyped viruses was also inhibited by NCOA7. Importantly, either overexpression of TMPRSS2, which promotes plasma membrane fusion versus endosomal fusion of SARS-CoV-2, or removal of Spike's polybasic furin cleavage site rendered SARS-CoV-2 less sensitive to NCOA7 restriction. Collectively, our data indicate that furin cleavage sensitizes SARS-CoV-2 Spike to the antiviral consequences of endosomal acidification by NCOA7, and suggest that the acquisition of furin cleavage may have favoured the co-option of cell surface TMPRSS proteases as a strategy to evade the suppressive effects of IFN-induced endo-lysosomal dysregulation on virus infection.
Identifiants
pubmed: 34807954
doi: 10.1371/journal.ppat.1009820
pii: PPATHOGENS-D-21-01487
pmc: PMC8648102
doi:
Substances chimiques
NCOA7 protein, human
0
Nuclear Receptor Coactivators
0
Protein Isoforms
0
Spike Glycoprotein, Coronavirus
0
Interferons
9008-11-1
Serine Endopeptidases
EC 3.4.21.-
TMPRSS2 protein, human
EC 3.4.21.-
FURIN protein, human
EC 3.4.21.75
Furin
EC 3.4.21.75
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e1009820Subventions
Organisme : Wellcome Trust
ID : 106223/Z/14/Z
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 207442/Z/17/Z
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_PC_15068
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_12014/10
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/W005611/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_PC_19026
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 201366/Z/16/Z
Pays : United Kingdom
Organisme : NIAID NIH HHS
ID : U54 AI150472
Pays : United States
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
J Virol. 2015 Jul;89(14):7202-13
pubmed: 25926653
Nat Commun. 2020 Sep 11;11(1):4541
pubmed: 32917884
J Virol. 2006 Feb;80(4):2013-8
pubmed: 16439557
Science. 2021 Jan 15;371(6526):288-292
pubmed: 33293339
Nat Microbiol. 2020 Apr;5(4):536-544
pubmed: 32123347
Science. 2020 Mar 27;367(6485):1444-1448
pubmed: 32132184
J Mol Histol. 2020 Dec;51(6):613-628
pubmed: 33011887
N Engl J Med. 2003 May 15;348(20):1977-85
pubmed: 12671062
Clin Transl Immunology. 2019 Aug 05;8(8):e1073
pubmed: 31406574
Autophagy. 2015;11(8):1437-8
pubmed: 26156798
Cell. 2020 Dec 10;183(6):1520-1535.e14
pubmed: 33157038
Cell Discov. 2020 Nov 4;6(1):80
pubmed: 33298900
Nat Commun. 2020 Nov 26;11(1):6013
pubmed: 33243994
Nature. 2021 Apr;592(7852):116-121
pubmed: 33106671
PLoS Pathog. 2020 Jul 29;16(7):e1008737
pubmed: 32726355
Nat Microbiol. 2020 Nov;5(11):1330-1339
pubmed: 32704094
Antiviral Res. 2020 Jul;179:104811
pubmed: 32360182
Elife. 2021 Jan 04;10:
pubmed: 33393462
Science. 2020 Nov 13;370(6518):856-860
pubmed: 33082293
Genome Med. 2020 Jul 28;12(1):68
pubmed: 32723359
Cell Res. 2021 Feb;31(2):126-140
pubmed: 33420426
Mol Cell. 2020 May 21;78(4):779-784.e5
pubmed: 32362314
Nature. 2021 Apr;592(7854):438-443
pubmed: 33690265
N Engl J Med. 2020 Feb 20;382(8):727-733
pubmed: 31978945
BMC Cell Biol. 2007 Mar 28;8:13
pubmed: 17391516
J Virol. 2020 Nov 9;94(23):
pubmed: 32938761
PLoS Pathog. 2021 Jan 25;17(1):e1009246
pubmed: 33493182
PLoS Pathog. 2021 Jan 19;17(1):e1009212
pubmed: 33465165
Cell. 2021 Jan 7;184(1):106-119.e14
pubmed: 33333024
J Virol. 2021 Apr 12;95(9):
pubmed: 33563656
Metabolism. 1997 Sep;46(9):1090-4
pubmed: 9284902
Nature. 2021 Mar;591(7849):293-299
pubmed: 33494095
PLoS One. 2013;8(1):e54290
pubmed: 23335997
Cell. 1998 Oct 30;95(3):409-17
pubmed: 9814710
Elife. 2021 Apr 09;10:
pubmed: 33835028
Immunity. 2021 Jun 8;54(6):1276-1289.e6
pubmed: 33836142
Emerg Infect Dis. 2005 Mar;11(3):411-6
pubmed: 15757556
Nat Rev Microbiol. 2021 Mar;19(3):155-170
pubmed: 33116300
Cell. 2020 Apr 16;181(2):281-292.e6
pubmed: 32155444
Nature. 2003 Nov 27;426(6965):450-4
pubmed: 14647384
Science. 2020 Oct 23;370(6515):
pubmed: 32972995
Adv Virus Res. 2018;100:163-188
pubmed: 29551135
Sci Rep. 2019 Jun 18;9(1):8682
pubmed: 31213630
J Clin Microbiol. 2010 Aug;48(8):2940-7
pubmed: 20554810
EMBO J. 2021 Aug 2;40(15):e107826
pubmed: 34101213
Proc Natl Acad Sci U S A. 2005 May 31;102(22):7988-93
pubmed: 15897467
Nature. 2020 May;581(7809):465-469
pubmed: 32235945
Nat Microbiol. 2018 Dec;3(12):1369-1376
pubmed: 30478388
Proc Natl Acad Sci U S A. 2009 Apr 7;106(14):5871-6
pubmed: 19321428
Epidemiol Infect. 1990 Oct;105(2):435-46
pubmed: 2170159
Nature. 2013 Mar 14;495(7440):251-4
pubmed: 23486063
J Virol. 2009 Aug;83(15):7411-21
pubmed: 19439480
Cell. 2021 Jan 7;184(1):76-91.e13
pubmed: 33147444
EMBO J. 2021 Feb 1;40(3):e106501
pubmed: 33270927
Cell. 2021 Jan 7;184(1):92-105.e16
pubmed: 33147445
J Virol. 1994 Feb;68(2):1213-8
pubmed: 8289354
Lancet. 2021 Feb 6;397(10273):452-455
pubmed: 33515491
Proc Natl Acad Sci U S A. 1988 Jun;85(12):4526-9
pubmed: 3380803
Emerg Microbes Infect. 2020 Dec;9(1):837-842
pubmed: 32301390
Nat Struct Mol Biol. 2020 Aug;27(8):763-767
pubmed: 32647346
Proc Natl Acad Sci U S A. 2020 May 26;117(21):11727-11734
pubmed: 32376634
Rev Med Virol. 2015 Nov;25(6):406-30
pubmed: 26467906
J Virol. 2018 Jul 17;92(15):
pubmed: 29769339
Nat Microbiol. 2021 Jul;6(7):899-909
pubmed: 33907312
Cell Rep. 2021 Jul 13;36(2):109364
pubmed: 34214467
Mol Cell Biol. 2002 May;22(10):3358-72
pubmed: 11971969
J Virol. 2021 Jan 29;:
pubmed: 33514628
Antiviral Res. 2020 Apr;176:104742
pubmed: 32057769
J Virol. 2012 Mar;86(5):2706-14
pubmed: 22205751
J Virol. 2000 Oct;74(19):9234-9
pubmed: 10982370
J Interferon Cytokine Res. 2015 Mar;35(3):186-99
pubmed: 25330068
Sci Rep. 2015 Dec 08;5:17916
pubmed: 26643317
Nat Biotechnol. 1997 Sep;15(9):871-5
pubmed: 9306402
Nat Commun. 2020 Mar 27;11(1):1620
pubmed: 32221306
Cell. 2020 May 28;181(5):1036-1045.e9
pubmed: 32416070
N Engl J Med. 2014 Jun 26;370(26):2499-505
pubmed: 24896817
Nat Commun. 2020 Jul 30;11(1):3810
pubmed: 32733001
Virology. 2018 Apr;517:9-15
pubmed: 29217279
PLoS Biol. 2021 Feb 25;19(2):e3001091
pubmed: 33630831
Proc Natl Acad Sci U S A. 2014 Oct 21;111(42):15214-9
pubmed: 25288733
Cell. 2020 Apr 16;181(2):271-280.e8
pubmed: 32142651
PLoS One. 2012;7(12):e50859
pubmed: 23227216
Proc Natl Acad Sci U S A. 2020 Dec 15;117(50):32105-32113
pubmed: 33239446
Nature. 2020 Jul;583(7816):459-468
pubmed: 32353859
EMBO J. 2020 Dec 1;39(23):e106267
pubmed: 33051876
Science. 2020 Dec 18;370(6523):1464-1468
pubmed: 33184236
Signal Transduct Target Ther. 2020 Jun 12;5(1):92
pubmed: 32532959
J Virol. 2015 Feb;89(3):1851-66
pubmed: 25428868
Annu Rev Immunol. 2014;32:513-45
pubmed: 24555472
iScience. 2021 Mar 19;24(3):102151
pubmed: 33585804
Life Sci Alliance. 2020 Jul 23;3(9):
pubmed: 32703818
Front Microbiol. 2020 Nov 25;11:593857
pubmed: 33324374